ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon
Olivier Fontaine, Nanobiotix, speaking at Nanomedicine 2014.
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart
Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials
Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Biomarker Development to Improve Trials for Type 1 Diabetes
Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Companion Diagnostics Development at the Siemens Clinical Laboratory
Sunil Pandit, Siemens Healthcare Diagnostics, speaking at Exosomes and Circulating Biomarkers 2013.
Esoteric Diagnostics in China: A Case Review of Building up the First and Largest Esoteric Laboratory Network in China
Shiang Huang, Kindstar Global, speaking at Point-of-Care Diagnostics World Congress 2013.
Your body is 3D, why is your cell culture not?
Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH
Companies in Translation with CIRM
Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012
Drug Discovery Outsourcing: the Importance of Integration in the Selection of Higher Quality Clinical Candidates
Simone Braggio, Director, Head of Drug Metabolism & Pharmacokinetics, Aptuit speaking at Pharma Outsourcing Congress 2011
RNA-Seq for High Throughput Clinical Studies
Wenzhong Xiao, Assistant Professor of Bioinformatics, Massachusetts General Hospital, speaking at Next-Gen Sequencing Congress 2011.
|<<|| 1 2 3 || >>|
|Showing Results 1 - 10 of 24|